Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations

  • René Böttcher1,
  • Charlotte F. Kweldam2,
  • Julie Livingstone3,
  • Emilie Lalonde3, 4,
  • Takafumi N. Yamaguchi3,
  • Vincent Huang3,
  • Fouad Yousif3,
  • Michael Fraser5,
  • Robert G. Bristow4, 5, 6,
  • Theodorus van der Kwast7,
  • Paul C. Boutros3, 4, 8,
  • Guido Jenster1 and
  • Geert J. L. H. van Leenders2Email author
Contributed equally
BMC Cancer201818:8

https://doi.org/10.1186/s12885-017-3976-z

Received: 17 May 2017

Accepted: 21 December 2017

Published: 2 January 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
17 May 2017 Submitted Original manuscript
10 Aug 2017 Reviewed Reviewer Report - Srinivasan Yegnasubramanian
18 Aug 2017 Reviewed Reviewer Report - Lloyd Trotman
27 Sep 2017 Author responded Author comments - René Böttcher
Resubmission - Version 2
27 Sep 2017 Submitted Manuscript version 2
17 Oct 2017 Reviewed Reviewer Report - Lloyd Trotman
26 Oct 2017 Reviewed Reviewer Report - Srinivasan Yegnasubramanian
24 Nov 2017 Author responded Author comments - René Böttcher
Resubmission - Version 3
24 Nov 2017 Submitted Manuscript version 3
Publishing
21 Dec 2017 Editorially accepted
2 Jan 2018 Article published 10.1186/s12885-017-3976-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Urology, Erasmus MC, Rotterdam, the Netherlands
(2)
Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands
(3)
Informatics & Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Canada
(4)
Department of Medical Biophysics, University of Toronto, Toronto, Canada
(5)
Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
(6)
Department of Radiation Oncology, University of Toronto, Toronto, Canada
(7)
Department of Pathology and Laboratory Medicine, Toronto General Hospital, University Health Network, Toronto, Canada
(8)
Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada

Advertisement